Laboratorios Hipra competitive analysis

Latest publications and patents of Laboratorios Hipra New

Explore the latest publications and patents granted to Laboratorios Hipra, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Laboratorios Hipra against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing ThemBOEHRINGER INGELHEIM ANIMAL HEALTH USAMar 4, 2021
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIM ANIMAL HEALTH USAFeb 24, 2021
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In PigsBOEHRINGER INGELHEIM ANIMAL HEALTH USASep 15, 2020
Vaccine Against Porcine Circo Virus Type 2INTERVETJul 10, 2020
Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIM ANIMAL HEALTH USAJan 8, 2020
Single Dose Anti-Pcv2 Pig VaccineBOEHRINGER INGELHEIM ANIMAL HEALTH USANov 20, 2019
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIM ANIMAL HEALTH USAOct 24, 2018

Latest PTAB cases involving Laboratorios Hipra

Discover the latest PTAB cases involving Laboratorios Hipra, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Laboratorios Hipra with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
LABORATORIOS HIPRA7 - - - Highly Aggressive
BOEHRINGER INGELHEIM ANIMAL HEALTH USA16302 - Balanced
BOEHRINGER INGELHEIM VETMEDICA1829 - 4Balanced
INTERVET113441Balanced